Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mirati Therapeutics Inc (NASDAQ:MRTX)

20.26
Delayed Data
As of Feb 05
 -1.10 / -5.15%
Today’s Change
19.69
Today|||52-Week Range
52.00
-35.89%
Year-to-Date
No recent news for Mirati Therapeutics Inc.

Today’s Trading

Previous close21.36
Today’s open21.21
Day’s range19.75 - 23.28
Volume162,056
Average volume (3 months)201,288
Market cap$390.3M
Dividend yield--
Data as of 4:00pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)+32.22%
Earnings growth (this year)-18.58%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book9.79

Competitors

 Today’s
change
Today’s
% change
SVASinovac Biotech Ltd-0.07-0.98%
TRVNTrevena Inc+0.16+2.17%
ARNAArena Pharmaceutical...-0.04-2.48%
FLMLFlamel Technologies ...-0.16-1.68%
Data as of 4:00pm ET, 02/05/2016

Financials

Next reporting dateMarch 9, 2016
EPS forecast (this quarter)-$0.97
Annual revenue (last year)$0.00
Annual profit (last year)-$43.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Charles M. Baum
Chief Operating Officer, Secretary &
Executive VP
Mark J. Gergen
Corporate headquarters
San Diego, California

Forecasts

Partner Offers